Labcorp director exercises 897 RSUs into shares

Labcorp Holdings Inc. director Kerrii B. Anderson reported the vesting and exercise of 897 Restricted Stock Units on February 11, 2026, converting them into an equal number of Labcorp common shares at $0 per share.

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Kerrii B. Anderson reported the vesting and exercise of 897 Restricted Stock Units on February 11, 2026, converting them into an equal number of Labcorp common shares at $0 per share. Following this derivative conversion, she directly holds 9,563 common shares and 773 remaining Restricted Stock Units, plus indirect holdings of 144 common shares in each of two separate trusts.

Insider Trade Summary

897 shares exercised/converted

Exercise 4 txns

Insider ANDERSON KERRII B

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	897	$0.00	$0.00
Exercise	Common Stock	897	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Unit — 773 contracts (Direct); Common Stock — 9,563 shares (Direct); Common Stock — 144 shares (Indirect, By Alexa M. Anderson Separate Trust); Common Stock — 144 shares (Indirect, By Cameron Taff Anderson Separate Trust)

Footnotes (3)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. The Restricted Stock Units vested fully on February 11, 2026.
3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) director Kerrii B. Anderson report?

Labcorp director Kerrii B. Anderson reported an exercise of 897 Restricted Stock Units on February 11, 2026, converting them into 897 Labcorp common shares at $0 per share. This reflects vesting of previously granted equity compensation.

How many Labcorp (LH) common shares does Kerrii B. Anderson hold after this Form 4?

After the reported transaction, Kerrii B. Anderson directly holds 9,563 Labcorp common shares. This figure comes from the Form 4’s post-transaction balance in Table I and reflects shares owned in her direct capacity as a director.

What happened to Kerrii B. Anderson’s Restricted Stock Units in the latest Labcorp (LH) filing?

On February 11, 2026, 897 of Kerrii B. Anderson’s Restricted Stock Units vested and were converted into the same number of Labcorp common shares. After this event, she continues to hold 773 Restricted Stock Units, according to the derivative securities table.

At what price were Kerrii B. Anderson’s Labcorp (LH) RSUs converted into common stock?

The 897 Restricted Stock Units reported were converted into Labcorp common shares at a price of $0 per share. This reflects typical settlement of equity awards granted as compensation, rather than an open-market purchase or sale transaction.

Does Kerrii B. Anderson have any indirect holdings of Labcorp (LH) stock?

Yes. The Form 4 shows indirect ownership of 144 Labcorp common shares in the Alexa M. Anderson Separate Trust and 144 shares in the Cameron Taff Anderson Separate Trust. These positions are reported as indirect beneficial ownership interests.

What does transaction code M mean in the Labcorp (LH) Form 4 for Kerrii B. Anderson?

Transaction code M indicates an exercise or conversion of a derivative security. In this case, it records Kerrii B. Anderson’s conversion of 897 Restricted Stock Units into an equal number of Labcorp common shares upon vesting on February 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 12:47 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDERSON KERRII B

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		897	A	(1)	9,563	D
Common Stock								144	I	By Alexa M. Anderson Separate Trust
Common Stock								144	I	By Cameron Taff Anderson Separate Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			897	(2)	(2)	Common Stock	897	$0	773(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vested fully on February 11, 2026.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle Attorney-in-Fact for Kerrii B. Anderson	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.